0
Skip to Content
Prova Health
Who we are
Clinical evidence
Economic evidence
Market access
Pharma
Digital health and AI innovators
Health systems
Our work
PH Insights
White papers
Learn by Prova Health
Get in touch • Get in touch • Get in touch • Get in touch • Get in touch • Get in touch
Prova Health
Who we are
Clinical evidence
Economic evidence
Market access
Pharma
Digital health and AI innovators
Health systems
Our work
PH Insights
White papers
Learn by Prova Health
Get in touch • Get in touch • Get in touch • Get in touch • Get in touch • Get in touch
Who we are
Folder: What we do
Back
Clinical evidence
Economic evidence
Market access
Folder: Who we work with
Back
Pharma
Digital health and AI innovators
Health systems
Folder: Knowledge
Back
Our work
PH Insights
White papers
Learn by Prova Health
Get in touch • Get in touch • Get in touch • Get in touch • Get in touch • Get in touch
Selected publications from our team Guest User 10/06/2024 Selected publications from our team Guest User 10/06/2024

Developed a white paper on digital health evidence with Roche and leading global experts

Read More
Selected publications from our team Guest User 09/06/2024 Selected publications from our team Guest User 09/06/2024

Evolution of the clinical simulation approach to assess digital health technologies (Future Healthcare Journal, 2023)

Read More
Selected publications from our team Guest User 07/06/2024 Selected publications from our team Guest User 07/06/2024

Generating evidence for digital health solutions (Healthcare Transformers, 2023)

Read More
Selected publications from our team Guest User 05/06/2024 Selected publications from our team Guest User 05/06/2024

Evaluation of prototype risk prediction tools for clinicians and people living with type 2 diabetes in North West London using the think aloud method (SAGE Digital Health, 2023)

Read More
Selected publications from our team Guest User 04/06/2024 Selected publications from our team Guest User 04/06/2024

General practitioners’ perceptions of using virtual primary care during the COVID-19 pandemic: An international cross-sectional survey study (PLOS Digital Health, 2022)

Read More
Selected publications from our team Guest User 03/06/2024 Selected publications from our team Guest User 03/06/2024

An Assessment of the NAVIFY Guidelines Application Using Clinical Simulation Research Methods (NCCN, 2022)

Read More
Selected publications from our team Guest User 02/06/2024 Selected publications from our team Guest User 02/06/2024

Evaluation of a clinical decision support tool for matching cancer patients to clinical trials using simulation-based research (Health Informatics Journal, 2022)

Read More
Selected publications from our team Guest User 01/06/2024 Selected publications from our team Guest User 01/06/2024

Assessing the safety of home oximetry for COVID-19: a multisite retrospective observational study (BMJ, 2021)

Read More
Selected publications from our team Guest User 31/05/2024 Selected publications from our team Guest User 31/05/2024

An assessment of the NAVIFY clinical trial match application using clinical simulation-based research methods (ASCO, 2021)

Read More
Selected publications from our team Guest User 30/05/2024 Selected publications from our team Guest User 30/05/2024

Usability and Acceptability of Home-based Self-testing for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibodies for Population Surveillance (Clinical Infectious Diseases, 2021)

Read More
Selected publications from our team Guest User 29/05/2024 Selected publications from our team Guest User 29/05/2024

A UK Survey of Current Methods for Conducting Cancer Multidisciplinary Team Meetings and Opportunities for Digital Solutions (IASLC, 2021)

Read More
Selected publications from our team Guest User 26/05/2024 Selected publications from our team Guest User 26/05/2024

Challenges for the evaluation of digital health solutions—A call for innovative evidence generation approaches (Nature Digital Medicine, 2020)

Read More
Selected publications from our team Guest User 25/05/2024 Selected publications from our team Guest User 25/05/2024

NHS data: Maximising its impact on the health and wealth of the United Kingdom (Imperial College London, 2020)

Read More
Selected publications from our team Guest User 02/05/2024 Selected publications from our team Guest User 02/05/2024

Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey (BMJ, 2020)

Read More
Selected publications from our team Guest User 01/05/2024 Selected publications from our team Guest User 01/05/2024

A mixed methods study for the evaluation of a digital health solution for cancer multidisciplinary team meetings using simulation-based research methods (ASCO, 2020)

Read More

Recent Posts

View all
Featured
Maximising pharma product launch success: How can pharmaceutical companies overcome systemic barriers to drug adoption? Featuring a case study in MASH
10 min read
Des Conroy
Maximising pharma product launch success: How can pharmaceutical companies overcome systemic barriers to drug adoption? Featuring a case study in MASH
10 min read
Des Conroy

Even the most groundbreaking drugs rarely reach their full commercial potential because of adoption friction: the structural and logistical realities that slow or limit their integration into health systems. Achieving a successful pharma product launch is difficult; 1 in 2 new drugs fail to meet launch forecasts. The emergence of the first treatments for MASH serves as a key case study, illustrating how diagnostic gaps, workforce shortages, and fragmented care create friction that leads to delayed or limited uptake. To maximise commercial success and ensure new products perform on launch expectations, companies must identify, characterise, and overcome the specific systemic barriers in key markets.

10 min read
Des Conroy
Rapid and safe evaluations of LLMs: how clinical simulation closes the evidence gap
10 min read
Gareth Obery
Rapid and safe evaluations of LLMs: how clinical simulation closes the evidence gap
10 min read
Gareth Obery

Large Language Models (LLMs) are reshaping healthcare, but how do we ensure they work safely and reliably for clinicians? Traditional trials are too slow and costly for digital health's rapid cycles, while early testing doesn't prove clinical validity. Clinical simulation offers a promising way forward, putting these tools in clinicians' hands, in realistic scenarios, to test their real-world performance. We believe this methodology should become a core part of how we validate LLM-based technologies before they reach clinical settings.

10 min read
Gareth Obery
Prova Health graphic pink

Accelerate the adoption of your digital health solution

Prova Health graphic blue
Get in touch
Prova Health Logo

Improving health for all by supporting innovation

Company

Who we are

Prova Health Network

Get in touch

What we do

Clinical evidence

Economic evidence

Market access

Knowledge

Our work

PH Insights


Privacy Policy

Website crafted by Crawford.

© Copyright 2024. All Rights Reserved by Prova Health Limited

Clinical evidence, economic evidence and market access for digital health and AI innovators

Company

Who we are

What we do

Get in touch

Knowledge

Our work


Privacy Policy

Website crafted by Crawford.

© Copyright 2024. All Rights Reserved by Prova Health Limited